Uptake of T-2307, a novel arylamidine, in Candida albicans

Journal of Antimicrobial Chemotherapy

Volumn 65, Issue 8, 2010, Pages 1681-1687

  Nishikawa, Hiroshi ^a   Yamada, Eio ^a   Shibata, Tatsuya ^a   Uchihashi, Shinsuke ^a   Fan, Haitian ^a   Hayakawa, Hiroyoshi ^a   Nomura, Nobuhiko ^a   Mitsuyama, Junichi ^a  

^a TOYAMA CHEMICAL CO LTD   (Japan)

Author keywords

Diamidine compounds; Potent antifungal activity; Transporter mediated systems

Indexed keywords

ANTIFUNGAL AGENT; CARBON 14; T 2307; UNCLASSIFIED DRUG; CARRIER PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACCUMULATION; DRUG POTENCY; DRUG UPTAKE; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PH; RAT; TEMPERATURE SENSITIVITY; ANIMAL; CELL CULTURE; DRUG EFFECTS; LIVER CELL; METABOLISM; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ANTIFUNGAL AGENTS; BIOLOGICAL TRANSPORT; CANDIDA ALBICANS; CELLS, CULTURED; HEPATOCYTES; MEMBRANE TRANSPORT PROTEINS; RATS;

EID: 77954754190     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkq177     Document Type: Article

References (33)

1. Pfaller MA, Diekema DJ, Jones RN et al. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 2001; 42: 1886-9.
2. White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998; 11: 382-402.
3. Denning DW. Echinocandin antifungal drugs. Lancet 2003; 362: 1142-51.
4. Thomas AH. Suggested mechanisms for the antimycotic activity of the polyene antibiotics and the N-substituted imidazoles. J Antimicrob Chemother 1986; 17: 269-79.
5. Mitsuyama J, Nomura N, Hashimoto K et al. In vitro and in vivo antifungal activities of T-2307, a novel arylamidine. Antimicrob Agents Chemother 2008; 52: 1318-24.
6. Goa KL, Campoli-Richards DM. Pentamidine isethionate: a review of its antiprotozoal activity, pharmacokinetic properties and therapeutic use in Pneumocystis carinii pneumonia. Drugs 1987; 33: 242-58.
7. Sands M, Kron MA, Brown RB. Pentamidine: a review. Rev Infect Dis 1985; 7: 625-34.
8. Sturk LM, Brock JL, Bagnell CR et al. Distribution and quantitation of the anti-trypanosomal diamidine 2,5-bis(4-amidinophenyl)furan (DB75) and its N-methoxy prodrug DB289 in murine brain tissue. Acta Trop 2004; 91: 131-43.
9. Yeates C. DB-289 Immtech International. IDrugs 2003; 6: 1086-93.
10. Carter NS, Barrett MP, De Koning HP. A drug resistance determinant from Trypanosoma brucei. Trends Microbiol 1999; 7: 469-71.
11. Damper D, Patton CL. Pentamidine transport and sensitivity in brucei group trypanosomes. J Protozool 1976; 23: 349-56.
12. Lanteri CA, Trumpower BL, Tidwell RR et al. DB75, a novel trypanocidal agent, disrupts mitochondrial function in Saccharomyces cerevisiae. Antimicrob Agents Chemother 2004; 48: 3968-74.
13. Basselin M, Denise H, Coombs GH et al. Resistance to pentamidine in Leishmania mexicana involves exclusion of the drug from the mitochondrion. Antimicrob Agents Chemother 2002; 46: 3731-8.
14. Mukherjee A, Padmanabhan PK, Sahani MH et al. Roles for mitochondria in pentamidine susceptibility and resistance in Leishmania donovani. Mol Biochem Parasitol 2006; 145: 1-10.
15. Wilcox LJ, Balderes DA, Wharton B et al. Transcriptional profiling identifies two members of the ATP-binding cassette transporter superfamily required for sterol uptake in yeast. J Biol Chem 2002; 277: 32466-72.
16. Hubbard MJ, Surarit R, Sullivan PA et al. The isolation of plasma membrane and characterisation of the plasma membrane ATPase from the yeast Candida albicans. Eur J Biochem 1986; 154: 375-81.
17. De Hoog GS, Guarro J, Gene J et al. Atlas of Clinical Fungi, 2nd edn. Utrecht: Centralbureau for Schimmelcultures, 2000; 184.
18. Webborn PJ, Parker AJ, Denton RL et al. In vitro-in vivo extrapolation of hepatic clearance involving active uptake: theoretical and experimental aspects. Xenobiotica 2007; 37: 1090-109.
19. White TC, Holleman S, Dy F et al. Resistance mechanisms in clinical isolates of Candida albicans. Antimicrob Agents Chemother 2002; 46: 1704-13.
20. Bowman BJ, Mainzer SE, Allen KE et al. Effect of inhibitors on the plasma membrane and mitochondrial adenosinetriphosphatases of Neurospora crassa. Biochem Biophys Acta 1978; 512: 13-28.
21. Glaser TA, Baatz JE, Kreishman GP et al. pH homeostasis in L. donovani amastigotes and promastigotes. Proc Natl Acad Sci USA 1988; 85: 7602-6.
22. Demaster EG, Mitchell A. A comparison of arsenate and vanadate as inhibitors or uncouplers of mitochondrial and glycolytic energy metabolism. Biochemistry 1973; 12: 3616-21.
23. De Koning HP. Transporters in African trypanosomes: role in drug action and resistance. Int J Parasitol 2001; 31: 512-22.
24. De Koning HP. Uptake of pentamidine in Trypanosoma brucei brucei is mediated by three distinct transporters: implications for cross-resistance with arsenicals. Mol Pharmacol 2001; 59: 586-92.
25. Barrett MP, Fairlamb AH. The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes. Parasitol Today 1999; 15: 136-40.
26. Barrett MP, Zhang ZQ, Denise H et al. A diamidine-resistant Trypanosoma equiperdum clone contains a P2 purine transporter with reduced substrate affinity. Mol Biochem Parasitol 1995; 73: 223-9.
27. De Koning HP, Jarvis SMA. Adenosine transporters in bloodstream forms of Trypanosoma brucei brucei: substrate recognition motifs and affinity for trypanocidal drugs. Mol Pharmacol 1999; 56: 1162-70.
28. Basselin M, Lawrence F, Robert-Gero M. Pentamidine uptake in Leishmania donovani and Leishmania amazonensis, promastigotes and amastigotes. Biochem J 1996; 315: 631-4.
29. Berman JD, Gallalee JV, Hansen BD. Leishmania mexicana: uptake of sodium stibogluconate (Pentostam) and pentamidine by parasite and macrophages. Exp Parasitol 1987; 64: 127-31.
30. Kandpal M, Balana-Fouce R, Pal A et al. Kinetics and molecular characteristics of arginine transport by Leishmania donovani promastigotes. Mol Biochem Parasitol 1995; 71: 193-201.
31. Kandpal M, Tekwani BL, Chauhan PMS et al. Correlation between inhibition of growth and arginine transport of Leishmania donovani promastigotes in vitro by diamidines. Life Sci 1996; 59: 75-80.
32. Basselin M, Coombs GH, Barrett MP. Putrescine and spermidine transport in Leishmania. Mol Biochem Parasitol 2000; 109: 37-46.
33. Shibata T, Takahashi T, Yamada E et al. T-2307, a novel arylamidine, disrupts mitochondrial function in yeast. In: Abstracts of the Forty-seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, IL, 2007. Abstract F-943, p. 235. American Society for Microbiology, Washington, DC, USA.